Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDLI | FATE | CLLS | ||
| Company | Pdl Biopharma Inc | Fate Therapeutics | Cellectis S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.73 | 2.51 | 2.85 | ||
| High | 2.78 | 2.56 | 2.85 | ||
| Low | 2.39 | 2.39 | 2.67 | ||
| Last | 2.47 | 2.45 | 2.75 | ||
| Change | -0.23 | -0.06 | -0.10 | ||
| Percent Change | -8.52% | -2.39% | -3.51% | ||
| Volume | 30,270,700 | 1,459,100 | 12,700 | ||
| 20-Day Average Volume | 4,709,610 | 2,373,750 | 14,115 | ||
| Previous | 2.70 | 2.51 | 2.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.58 | 2.74 | 2.88 | ||
| 20-Day Raw Stochastic | 17.78% | 20.41% | 20.25% | ||
| 20-Day Relative Strength | 46.04 | 49.27 | 42.10 | ||
| Weighted Alpha | -24.80 | +56.33 | -24.31 | ||
| Today's Opinion | 64% Sell | 80% Buy | 100% Sell | ||
| Yesterday's Opinion | 40% Sell | 80% Buy | 100% Sell | ||
| Last Month's Opinion | 56% Sell | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.26% since 12/22/20 | +1.66% since 07/24/26 | -3.17% since 07/24/26 | ||
| Low | 2.39 on 12/30/20 | 2.25 on 07/28/26 | 2.67 on 07/31/26 | ||
| High | 2.84 on 12/29/20 | 2.56 on 07/31/26 | 2.92 on 07/29/26 | ||
| 1-Month | |||||
| %Chg | -2.37% since 11/30/20 | -9.26% since 06/30/26 | -8.33% since 06/30/26 | ||
| Low | 2.39 on 12/30/20 | 2.25 on 07/28/26 | 2.59 on 07/20/26 | ||
| High | 2.84 on 12/29/20 | 3.23 on 07/13/26 | 3.39 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | -21.59% since 09/30/20 | +96.00% since 04/30/26 | -29.49% since 04/30/26 | ||
| Low | 2.09 on 11/02/20 | 1.24 on 05/01/26 | 2.59 on 07/20/26 | ||
| High | 3.24 on 10/01/20 | 3.23 on 07/13/26 | 4.19 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | -15.12% since 06/30/20 | +105.88% since 01/30/26 | -27.44% since 01/30/26 | ||
| Low | 2.09 on 11/02/20 | 1.04 on 03/19/26 | 2.59 on 07/20/26 | ||
| High | 3.78 on 08/19/20 | 3.23 on 07/13/26 | 4.55 on 04/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,141 | 285,570 | 275,932 | ||
| Shares Outstanding, K | 114,227 | 116,559 | 100,339 | ||
| Annual Sales, $M | 54,760,000 | 6,650,000 | 79,590,000 | ||
| Annual Net Income, $M | -70,410,000 | -136,320,000 | -67,590,000 | ||
| Last Qtr Sales, $M | 4,120,000 | 1,300,000 | 7,550,000 | ||
| Last Qtr Income, $M | 4,400,000 | -31,210,000 | -17,770,000 | ||
| 60-Month Beta | 1.11 | 2.51 | 2.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.26 on 05/13/26 | -0.18 on 05/11/26 | ||
| Latest Earnings Date | 12/31/21 | 08/11/26 | 08/03/26 | ||
| Most Recent Dividend | 0.050 on 06/02/16 | N/A | N/A | ||
| Next Ex-Dividend Date | 09/21/20 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||